CN117982375A - Vegetable oil composition for promoting cell proliferation and activity - Google Patents
Vegetable oil composition for promoting cell proliferation and activity Download PDFInfo
- Publication number
- CN117982375A CN117982375A CN202410132734.9A CN202410132734A CN117982375A CN 117982375 A CN117982375 A CN 117982375A CN 202410132734 A CN202410132734 A CN 202410132734A CN 117982375 A CN117982375 A CN 117982375A
- Authority
- CN
- China
- Prior art keywords
- oil
- sweet wormwood
- safflower seed
- seed oil
- vegetable oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 38
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 37
- 230000000694 effects Effects 0.000 title claims abstract description 34
- 230000004663 cell proliferation Effects 0.000 title claims abstract description 21
- 230000001737 promoting effect Effects 0.000 title claims abstract description 13
- 235000001405 Artemisia annua Nutrition 0.000 claims abstract description 73
- 240000000011 Artemisia annua Species 0.000 claims abstract description 73
- 239000003813 safflower oil Substances 0.000 claims abstract description 69
- 239000003921 oil Substances 0.000 claims abstract description 68
- 235000019198 oils Nutrition 0.000 claims abstract description 68
- 238000002360 preparation method Methods 0.000 claims abstract description 31
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 13
- 230000003833 cell viability Effects 0.000 claims abstract description 13
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 13
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 5
- 239000006071 cream Substances 0.000 claims description 13
- 239000006210 lotion Substances 0.000 claims description 9
- 230000001815 facial effect Effects 0.000 claims description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 5
- 239000005642 Oleic acid Substances 0.000 claims description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 5
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 5
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 3
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000008274 jelly Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 50
- 210000003491 skin Anatomy 0.000 description 50
- 239000006143 cell culture medium Substances 0.000 description 30
- 239000002609 medium Substances 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 13
- 239000002537 cosmetic Substances 0.000 description 12
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000012452 mother liquor Substances 0.000 description 10
- 210000002374 sebum Anatomy 0.000 description 10
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 9
- 239000003974 emollient agent Substances 0.000 description 9
- 239000010413 mother solution Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 210000002510 keratinocyte Anatomy 0.000 description 7
- 230000035899 viability Effects 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 229940082500 cetostearyl alcohol Drugs 0.000 description 5
- -1 etc. Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000008591 skin barrier function Effects 0.000 description 5
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 5
- PLQMEXSCSAIXGB-SAXRGWBVSA-N (+)-artemisinic acid Chemical compound C1=C(C)CC[C@H]2[C@H](C)CC[C@@H](C(=C)C(O)=O)[C@H]21 PLQMEXSCSAIXGB-SAXRGWBVSA-N 0.000 description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229930186526 Deoxyarteannuin Natural products 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 108090000991 Aquaporin 3 Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 2
- 239000004164 Wax ester Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- PLQMEXSCSAIXGB-UHFFFAOYSA-N artemisininic acid Natural products C1=C(C)CCC2C(C)CCC(C(=C)C(O)=O)C21 PLQMEXSCSAIXGB-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229960000281 trometamol Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000019386 wax ester Nutrition 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- XQVWYOYUZDUNRW-UHFFFAOYSA-N N-Phenyl-1-naphthylamine Chemical compound C=1C=CC2=CC=CC=C2C=1NC1=CC=CC=C1 XQVWYOYUZDUNRW-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001483078 Phyto Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- ZQGMLVQZBIKKMP-NNWCWBAJSA-N deoxyartemisinin Chemical compound C([C@](O1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C ZQGMLVQZBIKKMP-NNWCWBAJSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- ZQGMLVQZBIKKMP-UHFFFAOYSA-N desoxyartemisinin Natural products O1C(O2)(C)CCC3C(C)CCC4C32C1OC(=O)C4C ZQGMLVQZBIKKMP-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229940023565 ppg-10 cetyl ether Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000002824 redox indicator Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
The present invention provides a vegetable oil composition for promoting cell proliferation and viability, comprising sweet wormwood oil and safflower seed oil, wherein the volume ratio of sweet wormwood oil to safflower seed oil is equal to or less than 1:100. The sweet wormwood oil is obtained by extracting sweet wormwood by a supercritical extraction method. The safflower seed oil of the present invention comprises 50-90 wt% linoleic acid. The invention also relates to application of the vegetable oil composition in preparing medicines or external preparations for skin with the function of promoting cell proliferation and activity.
Description
Technical Field
The invention relates to the field of cosmetics, in particular to a vegetable oil composition containing sweet wormwood oil and safflower seed oil and application thereof in promoting cell proliferation and activity.
Background
Skin barriers broadly include physical barriers, nerve barriers, immune barriers, and the like. Skin barrier is a narrow definition of a physical barrier, which we refer to at ordinary times. The physical barrier consists of sebum membrane, keratin, lipid, sandwich structure, brick wall structure, dermis mucopolysaccharide, etc., and has effects of resisting external harmful substances, irritants, sunlight, keeping moisture, and regulating antiinflammatory. The basic function of sebum is to moisten and keep moisture, and meanwhile, the weak acidity of sebum can play a certain antibacterial role. Sebum forms a "sebum film" on the skin surface, and is a natural moisturizing cream for skin. If sebum is lacking, the skin barrier function is weakened, the sebum contains triglyceride, free fatty acid, wax ester, squalene and other components, and the sebum film can be rebuilt on the skin surface by smearing the moisturizing cream, so that the external stimulus can be effectively isolated, and meanwhile, the moisture of the skin is prevented from being lost.
Depending on the source and chemical composition of the grease, the grease can be divided into: vegetable oil, animal oil, mineral oil and synthetic oil, the vegetable oil is close to the structure of human sebum membrane due to the skin-friendly texture, has good permeability, deeply permeates and nourishes the skin, and is favored by a plurality of skin care products. Vegetable oils and fats for cosmetic use are mainly derived from fruits, seeds and germs of plants, and also partially derived from leaves, barks, roots, petals, pistils and other parts of plants.
Plant bionic lipid technology (Phyto Bionic Sebum, abbreviated as PBS technology): natural vegetable oil is selected, natural lipid components in the skin barrier structure are simulated through scientific proportion, unsaturated fatty acids such as linolenic acid, linoleic acid and the like which are necessary for supplementing the skin cuticle are supplemented, and lipid components which are lack of skin are supplemented, so that the skin barrier is quickly repaired, and the skin is in a state of being healthy, moist and glossy.
The sweet wormwood oil is extracted from sweet wormwood, and is light yellow to brown in color, and is obtained by extracting sweet wormwood by supercritical extraction. Sweet wormwood crude oil mainly contains: arteannuic acid, alpha-linolenic acid, deoxyarteannuin, palmitic acid, etc., has effects in inhibiting inflammation such as IL-1a; increasing skin moisture related gene expression such as FLG, AQP3, LOR, etc.
Safflower seed oil contains 6% saturated fatty acids, 21% oleic acid, 73% linoleic acid (by weight). The main component of the food oil is linoleic acid, which is the oil with the highest linoleic acid in the food oil, so the food oil has high nutritive value and is of great interest in medicine, food, cosmetics and the like. For example, the literature, bole, research progress on safflower seed oil, world LATEST MEDICINE Information (ElectronicVersion) [ J ],2021, 21 (27): 146-148, it is pointed out that safflower seed oil has an antioxidant effect, an ability to effectively scavenge free radicals and reduce free radicals caused by chemical factors, and an anti-aging effect. The literature Jiang Li shows that the safflower seed oil can effectively prevent atherosclerosis, reduce the content of blood fat and serum cholesterol, soften blood vessels and indirectly recover various drug effect functions such as nervous system and the like after long-term consumption of the safflower seed oil by analyzing the efficacy and application prospect of the safflower seed oil and agricultural product processing [ J ],2017, 6:56-58.
Cell proliferation is a key mechanism for repair of skin lesions. The change of the proliferation activity of cells is detected based on keratinocytes, and the change is generally used for evaluating the effects of rejuvenating skin and repairing damage of an object to be tested.
With the research and development of biological cytology, there are many methods for researching cell viability in recent years, and special reagents are mainly used for measuring the metabolic viability of cells, including alamarblue, MTT and other tetrazolium salts. Alamar blue is a redox indicator that produces a change in brightness and a fluorescent signal based on cellular metabolic activity. The method is simple to operate and has no toxic effect, and is commonly used for detecting cell proliferation and cell viability in recent years. The MTT method mainly reflects the energy generation of cells, and utilizes the principle that mitochondrial dehydrogenase can decompose yellow MTT into blue-violet formazan energy in the growth and proliferation process of living cells to detect the change of the number and the activity of the cells, so that the MTT method is a simple and accurate common method for detecting the proliferation and the activity of the cells.
According to the invention, the vegetable oil composition of the sweet wormwood oil and the safflower seed oil is adopted for the first time, the proliferation and activity effects of the vegetable oil composition on skin epidermal cells are examined, and the unexpected finding that the effect of promoting cell proliferation and activity of the vegetable oil composition is obviously better than the effect of independently using the sweet wormwood oil and the safflower seed oil.
Disclosure of Invention
In one aspect, the present invention provides a vegetable oil composition for promoting cell proliferation and viability comprising sweet wormwood oil and safflower seed oil, wherein the volume ratio of sweet wormwood oil to safflower seed oil is equal to or less than 1:100, preferably the volume ratio is 1:100 to 1:800.
In a preferred embodiment, the sweet wormwood oil is obtained by extracting sweet wormwood by a supercritical extraction method.
In a preferred embodiment, the safflower seed oil comprises 50 to 90 wt% linoleic acid. More preferably, the safflower seed oil comprises 6 wt.% saturated fatty acids, 21 wt.% oleic acid, and 73 wt.% linoleic acid.
In another aspect, the present invention also relates to the use of a vegetable oil composition comprising sweet wormwood oil and safflower seed oil, wherein the volume ratio of sweet wormwood oil to safflower seed oil is equal to or less than 1:100, for the preparation of a medicament or a skin external preparation having an effect of promoting cell proliferation and viability.
In a preferred embodiment, the vegetable oil composition is contained in an amount of 0.001 to 20% by weight, preferably 0.01 to 5% by weight, in the pharmaceutical or skin external preparation.
In a preferred embodiment, the skin external agent is selected from the group consisting of: face cream, milky lotion, jelly, pack, face toilet, pack, aerosol cleansing foam, spray, body wash, or facial cleanser.
Brief description of the drawings
Figure 1 shows mass spectrum data of sweet wormwood oil. The sweet wormwood oil comprises 10-60% of sweet wormwood acid, 1-20% of alpha-linolenic acid and 1-20% of deoxyartemisinin by weight.
FIG. 2 shows the results of the plant oil compositions of comparative example 1 and examples 1-9 promoting cell viability (cell viability).
Detailed Description
The invention adopts the vegetable oil composition of the sweet wormwood oil and the safflower seed oil for the first time, and examines the proliferation and activity of the vegetable oil composition on skin epidermal cells. In addition, the vegetable oil composition containing sweet wormwood oil and safflower seed oil can be used as an efficacy combination additive to be applied to external skin preparations for promoting proliferation and activity of cells.
In order to provide a more concise description, some quantitative representations presented herein are not modified by the term "about". It will be understood that each quantity given herein is intended to refer to an actual given value, whether or not the term "about" is explicitly used, and is also intended to refer to approximations of such given values, including approximations of such given values resulting from experimental and/or measurement conditions, as reasonably deduced by one of ordinary skill in the art.
To provide a more concise description, some quantitative expressions herein are recited as a range from about X to about Y. It should be understood that when a range is recited, the range is not limited to the recited upper and lower limits, but rather, includes the entire range of about X to about Y amounts or any amount therebetween.
Sweet wormwood oil
The sweet wormwood oil is extracted from sweet wormwood, and is light yellow to brown in color, and is obtained by extracting sweet wormwood by supercritical extraction. Sweet wormwood crude oil mainly contains: arteannuic acid, alpha-linolenic acid, deoxyarteannuin, palmitic acid, etc., has effects in inhibiting inflammation such as IL-1a; increasing skin moisture related gene expression such as FLG, AQP3, LOR, etc.
In an embodiment of the present invention, sweet wormwood oil purchased from Shanghai household Biotechnology Co., ltd.
In a preferred embodiment, the sweet wormwood oil is extracted by supercritical fluid extraction. In some embodiments, the extraction process of sweet wormwood oil comprises the following steps: (a) Extracting herba Artemisiae Annuae with supercritical fluid to obtain crude extract of oleum Artemisiae Annuae; (b) re-dissolving the crude sweet wormwood oil extract and centrifuging; (c) And taking supernatant, decoloring, filtering and concentrating to obtain sweet wormwood oil.
In some embodiments, step (a) employs sweet wormwood having a particle size of 10-30 mesh. In a specific embodiment, step (a) employs sweet wormwood having a particle size of 20 mesh. In some embodiments, step (a) is performed at a pressure of 10 to 40 MPa. In a preferred embodiment, step (a) is carried out at a pressure of 20 to 40MPa or 30 to 40 MPa. In some embodiments, step (a) is performed at a temperature of 40-60 ℃. In a specific embodiment, step (a) is performed at a temperature of 50 ℃. In some embodiments, step (b) employs ethanol reconstitution, preferably 95% ethanol reconstitution. In some embodiments, the centrifugation conditions of step (b) are 3500rpm. In some embodiments, step (c) is decolorized with activated carbon powder. In a specific embodiment, supercritical extraction is performed using a south-Tong intelligent supercritical device RZSCF, 230-50-10L.
Fig. 1 shows the results of the composition analysis of sweet wormwood oil. As shown in FIG. 1, the sweet wormwood oil component preferably comprises 10-60% of sweet wormwood acid, 1-20% of alpha-linolenic acid and 1-20% of deoxyarteannuin by relative mass.
In some embodiments, the sweet wormwood oil is used at a concentration of at least 0.0001% by volume. In some embodiments, the sweet wormwood oil is used at a concentration of at least 0.000125% by volume.
Safflower seed oil
The main component of the safflower seed oil is linoleic acid, which is the highest linoleic acid in the food oil, so the safflower seed oil has high nutritive value and is of great interest in medicine, food, cosmetics and the like. Safflower seed oil contains 50-90 wt% linoleic acid. In a specific embodiment, the safflower seed oil comprises 6% saturated fatty acids, 21% oleic acid, 73% linoleic acid by weight.
In an embodiment of the present invention, safflower seed oil from the company natural vegetable oil, north british (Northstar Lipids UK ltd.) was used.
In some embodiments, safflower seed oil is used at a concentration of at least 0.01% by volume. In some embodiments, safflower seed oil is used at a concentration of at least 0.0125% by volume.
In some embodiments, safflower seed oil is used at a concentration of 0.0125% to 0.1% by volume.
In some embodiments, the volume ratio of sweet wormwood oil to safflower seed oil is equal to or less than 1:100. In some embodiments, the volume ratio of sweet wormwood oil to safflower seed oil is 1:100 to 1:800.
External preparation for skin containing vegetable oil composition
The vegetable oil composition of the present invention can be applied as an efficacy additive to skin external preparations for promoting cell proliferation and viability, thereby improving skin conditions.
In some embodiments, the vegetable oil composition is present in the skin external agent in an amount of 0.001 to 20% by weight, preferably 0.01 to 5% by weight.
In some embodiments, the skin external agent is selected from the group consisting of: face creams, lotions, gels, lotions, essences, face masks, eye creams, aerosols (cleansing bubbles), sprays, body washes and facial washes. Different amounts are added according to the different types of formulations.
The external skin preparation is a general concept of all ingredients commonly used outside the skin, and may be, for example, a cosmetic composition. The cosmetic composition may be basic cosmetic, facial makeup cosmetic, body cosmetic, hair care cosmetic, etc., and its dosage form is not particularly limited and may be reasonably selected according to different purposes. The cosmetic composition also contains various cosmetically acceptable medium or matrix excipients depending on dosage form and purpose.
The external preparation for skin contains a dermatologically acceptable carrier or vehicle (e.g., a lotion, a cream, an ointment, a cleanser, etc.). The person of ordinary skill in the art will be able to select a carrier that will dissolve or disperse these components at the concentrations described above, in accordance with common general knowledge in the art. When a carrier is used, the carrier should not cause inactivation of the vegetable oil composition and should not cause any adverse effect on the skin upon use.
The person of ordinary skill in the art will be able to select suitable carriers, including, for example, water, alcohols, oils, etc., based on common general knowledge and their ability to dissolve or disperse in the active ingredient at a concentration most suitable for treatment.
The skin external preparation of the present invention may be in the form of a topical application product which can be externally applied to the skin and can be prepared by those ordinary techniques well known in the art. The carrier may take a variety of practical forms, such as creams, dressings, gels, lotions, ointments or liquids, including compositions for application and cleansing, and incorporating them into a carrier material such as a dry or wet spread, hydrogel matrix, or adhesive (or non-adhesive) patch by methods well known in the art. Preferably, the carrier is a gel or a moisturizing lotion, or an application in dry or wet form.
Typical carriers include emulsions comprising water and/or an alcohol and an emollient, wherein the emollient is, for example, a hydrocarbon oil and wax, silicone oil, hyaluronic acid, a vegetable, animal or marine fat or oil, a glyceride derivative, a fatty acid, or fatty acid ester or alcohol ether, lanolin and its derivatives, a polyol or ester, a wax ester, a sterol, a phospholipid, and the like, and typically also an emulsifier (nonionic, cationic or anionic), although some emollients themselves have emulsifying properties. In addition, these same components may be formulated into creams, gels, or solid sticks using different proportions of their components and/or by incorporating thickeners such as gums or other forms of hydrocolloids.
The skin external agent of the present invention may contain additional components commonly found in skin care compositions, such as emollients, skin conditioning agents, emulsifiers, preservatives, antioxidants, fragrances, chelating agents, and the like, as long as they are physically and chemically compatible with the other components of the skin external agent and do not affect the effects of the vegetable oil composition of the present invention.
In some embodiments of the skin external preparation of the present invention, one or more preservatives may be used. Suitable preservatives include p-hydroxyacetophenone, alkyl C1-C4 p-hydroxybenzoates and phenoxyethanol. The preservative is used in an amount of about 0.5 to about 2 wt%, preferably about 0.5 to 1 wt%, based on the total weight of the composition.
In one example of the skin external agent of the present invention, one or more antioxidants may be used. Suitable antioxidants include Butylated Hydroxytoluene (BHT), ascorbyl palmitate (BHA), butylated hydroxyanisole, phenyl-alpha-naphthylamine, hydroquinone, propyl gallate, nordihydroguaiaretic acid, vitamin E or derivatives of vitamin E, vitamin C and its derivatives, calcium pantothenate, green tea extracts and mixed polyphenols, and mixtures of the foregoing. The antioxidants are used in an amount ranging from about 0.02 to 0.5 weight percent, more preferably from about 0.002 to 0.1 weight percent, based on the total weight of the composition.
In one example of the skin external agent of the present invention, one or more emollients may be used which act as lubricants to reduce flaking and improve the appearance of the skin by their ability to remain on the skin surface or in the stratum corneum. Typical emollients include fatty esters, fatty alcohols, mineral oils, polyether siloxane copolymers, and the like. Examples of suitable emollients include, without limitation, polypropylene glycol ("PPG") -15 stearyl ether, PPG-10 cetyl ether, steareth-10, oleth-8, PPG-4 lauryl ether, vitamin E acetate, lanolin, cetyl alcohol, cetostearyl alcohol ethyl hexanoate, cetostearyl alcohol, glyceryl stearate, octyl hydroxystearate, dimethylpolysiloxane, and combinations thereof. Cetyl alcohol, cetostearyl alcohol ethyl hexanoate, cetostearyl alcohol, glycerol stearate, and combinations thereof are preferred. When used, the emollient is in an amount ranging from about 0.1 to about 30 weight percent, preferably from about 1 to about 30 weight percent, based on the total weight of the composition.
In one example of the skin external agent of the present invention, one or more moisturizers may be used. Humectants, also known as humectants, help to enhance the effectiveness of emollients, reduce flaking, stimulate removal of constituent scales and enhance skin feel. Polyols may be used as humectants including, but not limited to, glycerin, polyalkylene glycols, alkylene polyols and derivatives thereof, including butylene glycol, propylene glycol, dipropylene glycol, polyglycerol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1, 3-dibutylene glycol, 1,2, 6-hexanetriol, ethoxylated glycerin, propoxylated glycerin and combinations thereof. When used, the humectant is present in an amount of about 0.1 to about 20 weight percent, preferably about 1 to about 15 weight percent, based on the total weight of the composition.
In one example of the skin external agent of the present invention, one or more emulsifying agents may be used. The emulsifier may be used in an effective stabilizing amount. Preferably, the emulsifier is used in an amount of about 1.0 to about 10.0 wt%, more preferably about 3.0 to about 6.0 wt%, based on the total weight of the composition. Any emulsifier that is compatible with the components of the composition may be used. Suitable emulsifiers include stearic acid, cetyl alcohol, glyceryl stearate, lecithin, stearyl alcohol, steareth-2, steareth-20, acrylic/C10-30 alkanol acrylate cross-linked polymers, and combinations thereof.
In one example of the skin external agent of the present invention, one or more pH adjusting agents may be used. The pH adjuster useful in the skin external preparation of the present invention includes tromethamine. When used, the pH adjustor is used in an amount of about 0.1 to about 2 weight percent, preferably about 0.1 to about 1 weight percent, based on the total weight of the composition.
In one embodiment of the present invention, the skin external preparation comprises acrylic/C10-30 alkanol acrylate cross-linked polymer, glycerol, p-hydroxyacetophenone, glycerol stearate and lecithin, cetyl/stearyl alcohol, cetostearyl alcohol ethyl hexanoate, tromethamine or combinations thereof.
In some embodiments of the present invention, the vegetable oil composition is used in an amount of 0.001% -20% (w/w), preferably 0.01% -20% (w/w), more preferably 0.01% -10% (w/w), and most preferably 0.1% -5% (w/w) of the skin external preparation.
Examples
The invention will be further illustrated by the following examples. It should be noted that the scope of the present invention is not limited to these embodiments, but is intended to illustrate the technical solution of the present invention and not to limit the scope of the present invention. The experimental procedures, which do not address the specific conditions in the examples below, are generally performed under conventional conditions or under conditions recommended by the manufacturer. The percentages of sweet wormwood oil and safflower seed oil in the following comparative examples and examples are calculated by volume.
1. Experimental materials
Safflower (CARTHAMUS TINCTORIUS) seed oil, trade name safflower seed oil, purchased from Northstar Lipids UK ltd;
sweet wormwood oil is purchased from Shanghai household Biotechnology Co.
2. Instrument and reagent
Instrument: bench top centrifuges, CO 2 incubator HERAcell i, microplate reader Multiskan Mk3 (Thermo), biosafety cabinet 1300 services A2, and the like.
Reagent: MTT assay kit (Sigma), DMEM high-glucose medium (Gibco 11995065), FBS, PBS (Soxhibao), dimethyl sulfoxide (DMSO, sigma).
3. Reagent configuration:
DMEM complete medium: adding FBS into DMEM high sugar culture medium to make its content 10%, and storing at 4deg.C.
Comparative example 1 cell culture medium:
According to the calculation, the DMSO addition amount in each example is not more than 0.1%, and the culture medium in comparative example 1 is selected from DMEM complete culture medium with DMSO content of 0.1% because the culture medium has no cytotoxicity in combination with previous data that the DMSO addition amount is less than 0.1%.
Comparative example 1 cell culture medium: 1ml of comparative example 1 cell culture medium = 1 μl DMSO +999 μ lDMEM complete medium, a culture medium of comparative example 1 was obtained with DMSO content of 0.01%.
Example 1 cell culture medium:
Preparing mother solution: sweet wormwood oil and DMSO are prepared according to a volume ratio of 1:499.
Example 1 cell culture medium: 1ml of example 1 cell culture medium = 0.625 μl of mother liquor +999.375 μl of DMEM complete medium, resulting in the culture medium of example 1 having an oil content of 0.000125% in artemisia annua.
Example 2 cell culture medium:
preparing mother solution: safflower seed oil and DMSO are prepared according to a volume ratio of 1:1.
Example 2 cell culture medium: 1ml of cell culture medium of example 2 = 0.25 μl of mother liquor +999.75 μ lDMEM complete medium, resulting in the culture medium of example 2 with safflower seed oil content of 0.0125%.
Example 3 cell culture medium:
preparing mother solution: safflower seed oil and DMSO are prepared according to a volume ratio of 1:1.
Example 3 cell culture medium: 1ml of cell culture medium of example 3 = 0.5 μl of mother liquor +999.5 μ lDMEM complete medium, resulting in the culture medium of example 3 having a safflower seed oil content of 0.025%.
Example 4 cell culture medium:
preparing mother solution: safflower seed oil and DMSO are prepared according to a volume ratio of 1:1.
Example 4 cell culture medium: 1ml of cell culture medium of example 4 = 1 μl of mother liquor +999 μl of DMEM complete medium, resulting in the culture medium of example 4 with safflower seed oil content of 0.05%.
Example 5 cell culture medium:
preparing mother solution: safflower seed oil and DMSO are prepared according to a volume ratio of 1:1.
Example 5 cell culture medium: 1ml of cell culture medium of example 5 = 2 μl mother liquor +998 μl DMEM complete medium, resulting in the culture medium of example 5 with safflower seed oil content of 0.1%.
Example 6 cell culture medium:
preparing mother solution: sweet wormwood oil: safflower seed oil: DMSO was formulated at a volume ratio of 1:100:99.
Example 6 cell culture medium: 1ml of cell culture medium of example 1 = 0.25 μl of mother liquor +999.75 μ lDMEM complete medium, resulting in the medium of example 6 having an sweet wormwood oil content of 0.000125% and a safflower seed oil content of 0.125%.
Example 7 cell culture medium:
preparing mother solution: sweet wormwood oil: safflower seed oil: DMSO was formulated at a volume ratio of 1:200:199.
Example 7 cell culture medium: 1ml of cell culture medium of example 1 = 0.5 μl of mother liquor +999.5 μ lDMEM complete medium, resulting in the medium of example 7 having an sweet wormwood oil content of 0.000125% and a safflower seed oil content of 0.025%.
Example 8 cell culture medium:
Preparing mother solution: sweet wormwood oil: safflower seed oil: DMSO was configured at a volume ratio of 0.5:200:199.5.
Example 8 cell culture medium: 1ml of example 1 cell culture medium = 1 μl of mother liquor +999 μl of DMEM complete medium, resulting in the culture medium of example 8 having an sweet wormwood oil content of 0.000125% and a safflower seed oil content of 0.05%.
Example 9 cell culture medium:
Preparing mother solution: sweet wormwood oil: safflower seed oil: DMSO was formulated at a volume ratio of 0.5:400:399.5.
Example 9 cell culture medium: 1ml of cell culture medium of example 1 = 2 μl mother liquor +998 μl DMEM complete medium, resulting in the culture medium of example 9 having an sweet wormwood oil content of 0.000125% and a safflower seed oil content of 0.1%.
Table 1 summarizes the amounts and proportions of sweet wormwood oil and safflower seed oil per ml of medium in the examples.
TABLE 1
Test example 1: comparative example 1 and examples 1, 2, 6 keratinocyte viability test
The invention adopts a method for testing the cell viability of human immortalized keratinocytes Hacat, and adds a proper amount of samples prepared in the examples into keratinocytes and incubates for 24 hours. After 24 hours, the samples were washed away and tested for cell viability using the MTT method. The ability of the samples of the examples to promote cell proliferation and cell viability can be evaluated based on the increase in viability.
Hacat cell seed plate
The medium in the T175 flask was discarded, washed once with PBS, digested with 0.25% EDTA trypsin for 1min, then fresh medium was added to stop the digestion, the cell suspension was transferred to a 15mL centrifuge tube, centrifuged at 800rpm for 5min, and the supernatant was discarded. Cell counts were performed after resuspension with DMEM complete medium. The cell suspension was diluted to a density of 8000 cells/100. Mu.l and inoculated in 96-well plates at 100. Mu.l/well, and after the completion of the inoculation, cultured in a 5% CO2 incubator at 37℃for 24 hours.
Cell processing and sample addition
Taking out the 96-well plate, discarding the supernatant, adding the culture medium corresponding to comparative example 1 and examples 2, 3 and 6, 100 mu L/well, and culturing in a 5% CO2 incubator at 37 ℃ for 24 hours;
Cell proliferation and viability assays
Preparing MTT mother liquor: 25mg of MTT was dissolved in 5ml of MTT solvent to prepare a 5mg/ml MTT solution.
MTT solution configuration: the preparation was carried out in a ratio of 10. Mu. lMTT solution to 90. Mu.l of DMEM complete medium.
Sample adding: the original medium was removed, 100. Mu.l of the MTT solution described above was added to each well, and incubation was continued for 4 hours in the cell incubator.
Dissolving: the MTT solution was carefully removed, 100. Mu.l DMSO was added to each well and mixed well and incubation was continued in the cell incubator. Until the crystalline dark purple product formazan was found to be totally dissolved by observation under a common light microscope.
Absorbance measurement: the absorbance was measured at 570nm by a microplate reader.
Result judgment
Comparative example 1 is an unslotted group with relative viability of 100%; the examples containing sweet wormwood oil and safflower seed oil were compared with comparative example 1 and examples containing equal amounts of sweet wormwood oil and safflower seed oil alone. If the cell proliferation rate and the cell activity are obviously higher than those of other groups, the composition is considered to have better effects of promoting the cell proliferation and the cell activity, and has better effects of reviving skin and repairing injury.
Experimental results
As shown in Table 2, compared with the sweet wormwood oil and the safflower seed oil which are singly used in the same concentration, the sweet wormwood oil and the safflower seed oil are compounded according to the volume ratio of 1:100, and the effect of obviously enhancing the cell proliferation and the activity is achieved.
TABLE 2
The above p-value calculations are all compared with example 6.
Test example 2: comparative example 1 and examples 1, 3, 7 keratinocyte viability test
The test was performed using the same experimental procedure as in test example 1.
Experimental results:
As shown in Table 3, compared with the sweet wormwood oil and the safflower seed oil which are singly used in the same concentration, the sweet wormwood oil and the safflower seed oil are compounded according to the volume ratio of 1:200, and the effect of obviously enhancing the cell proliferation and the activity is achieved.
TABLE 3 Table 3
The above p-value calculations are all compared with example 7.
Test example 3: comparative example 1 and examples 1, 4, 8 keratinocyte viability test
The test was performed using the same experimental procedure as in test example 1.
Experimental results:
as shown in Table 4, compared with the sweet wormwood oil and the safflower seed oil which are singly used in the same concentration, the sweet wormwood oil and the safflower seed oil are compounded according to the volume ratio of 1:400, and the effect of obviously enhancing the cell proliferation and the activity is achieved.
TABLE 4 Table 4
The above p-value calculations are all compared with example 8.
Test example 4: comparative example 1 and examples 1, 5, 9 keratinocyte viability test
The test was performed using the same experimental procedure as in test example 1.
Experimental results:
As shown in Table 5, compared with the sweet wormwood oil and the safflower seed oil which are singly used in the same concentration, the sweet wormwood oil and the safflower seed oil are compounded according to the volume ratio of 1:800, and the effect of obviously enhancing the cell proliferation and the activity is achieved.
TABLE 5
The above p-value calculations are all compared with example 9.
The vegetable oil composition can be used as an efficacy additive and applied to skin external preparations, and the skin external preparations are preferably cosmetic compositions, including but not limited to preparation of products in forms of face cream, emulsion, gel, toning lotion, essence, facial mask, eye cream, aerosol (cleaning foam), spray, bath lotion, facial cleanser and the like. For example, the vegetable oil compositions of examples 6,7, 8 and 9 were used in an amount of 0.0001% to 20% (w/w) by weight in the skin external preparation. Preferably 0.001% to 10% (w/w). More preferably 0.001% to 5% (w/w). Most preferably 0.01% -5% (w/w) by weight.
The following are specific examples of application of the vegetable oil composition of the examples in skin external preparations, and formulations and preparation methods of these dosage forms. Specific applications are as follows:
Application example 1: preparation of face cream
Application example 2: preparation of the emulsion
Application example 3: preparation of eye cream
Application example 4: preparation of facial mask
/>
Application example 5: preparation of essence
/>
/>
Claims (12)
1. A vegetable oil composition that promotes cell proliferation and viability, the vegetable oil composition comprising sweet wormwood oil and safflower seed oil, wherein the volume ratio of sweet wormwood oil to safflower seed oil is equal to or less than 1:100.
2. The vegetable oil composition of claim 1, wherein the volume ratio of sweet wormwood oil to safflower seed oil is 1:100 to 1:800.
3. The vegetable oil composition according to claim 1, wherein the sweet wormwood oil is obtained by extracting sweet wormwood herb by a supercritical extraction method.
4. The vegetable oil composition of claim 1, wherein the safflower seed oil comprises 50-90 wt.% linoleic acid.
5. The vegetable oil composition of claim 1, wherein the safflower seed oil comprises 6 wt.% saturated fatty acids, 21 wt.% oleic acid, and 73 wt.% linoleic acid.
6. Use of a vegetable oil composition comprising sweet wormwood oil and safflower seed oil in a volume ratio of sweet wormwood oil to safflower seed oil of 1:100 or less for the preparation of a medicament or a skin external preparation having an effect of promoting cell proliferation and viability.
7. The use according to claim 6, wherein the sweet wormwood oil is obtained by extracting sweet wormwood by supercritical extraction.
8. The use according to claim 6, wherein the safflower seed oil comprises 50-90% by weight linoleic acid.
9. The use according to claim 6, wherein the safflower seed oil comprises 6 wt.% saturated fatty acids, 21 wt.% oleic acid and 73 wt.% linoleic acid.
10. The use as claimed in claim 6, wherein the vegetable oil composition is contained in an amount of 0.001 to 20% by weight in the pharmaceutical or external skin preparation.
11. The use as claimed in claim 10, wherein the vegetable oil composition is contained in an amount of 0.01 to 5% by weight in the pharmaceutical or dermatological external preparation.
12. The use according to claim 6, wherein the external skin preparation is selected from the group consisting of: face cream, milky lotion, jelly, pack, face toilet, pack, aerosol cleansing foam, spray, body wash, or facial cleanser.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410132734.9A CN117982375A (en) | 2024-01-30 | 2024-01-30 | Vegetable oil composition for promoting cell proliferation and activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410132734.9A CN117982375A (en) | 2024-01-30 | 2024-01-30 | Vegetable oil composition for promoting cell proliferation and activity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117982375A true CN117982375A (en) | 2024-05-07 |
Family
ID=90900442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410132734.9A Pending CN117982375A (en) | 2024-01-30 | 2024-01-30 | Vegetable oil composition for promoting cell proliferation and activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117982375A (en) |
-
2024
- 2024-01-30 CN CN202410132734.9A patent/CN117982375A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109846757B (en) | Sebum biomimetic composition and cosmetic containing same | |
JP2021020887A (en) | Enhanced anti-aging cosmetic composition | |
US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
KR101275971B1 (en) | Composition for antioxidation effect comprising sparassis crispa extract | |
CN109453087B (en) | Whitening skin-penetrating lotion, preparation method thereof and whitening cosmetic additive | |
CN114129476A (en) | Composition comprising vegetable fruit oil and vegetable seed oil and use thereof | |
CN114224787A (en) | Composition containing vegetable seed oil and fat and application thereof | |
KR101352363B1 (en) | Composition of skin external application for moisturizing comprising Scrophularia buergeriana Miq. extract | |
KR20020040669A (en) | Agents improving skin barrier function | |
US20180140537A1 (en) | Active complex for a cosmetic product against skin ageing | |
KR20130031988A (en) | Skin external composition containing floral ginsenoside | |
CN110801412B (en) | Sebum bionic composition, application thereof and cosmetics | |
TW202106323A (en) | Use ofrosmarinus officinaliscallus extract for manufacturing composition inhibiting skin aging and a culture medium for inducingrosmarinus officinaliscallus | |
KR20210095341A (en) | A composition comprising spirulina extract for skin regeneration | |
KR101708459B1 (en) | Cosmetic composition for moisturizing and elasiticity of skin containing the LAMINARIA JAPONICA extract, UNDARIA PINNATIFIDA extract and PLANTAGO ASIATICA SEED extract | |
KR20170010499A (en) | Cosmetic Compositions comprising Snail mucus fermentation filtrate for improving skin barrier function and having high skin absorption and Functional Cosmetic using this | |
KR100532633B1 (en) | Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract | |
CN117982375A (en) | Vegetable oil composition for promoting cell proliferation and activity | |
CN114177119A (en) | Composition containing vegetable fruit oil and fat and application thereof | |
CN112807254A (en) | Skin repair composition and application thereof in cosmetics | |
KR20160020038A (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
KR20160000318A (en) | Cosmetic composition containing Fir tree oil | |
KR20210025870A (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Ganoderma lucidum, Arnica montana, Buddleja, Thymus vulgaris, Sigesbeckia Orientalis and Rabdosia rubescens as Active Ingredient | |
KR20150034371A (en) | Cosmetic composition comprising the extract of Commelina communis as anti-wrinkle ingredient | |
KR101910865B1 (en) | External composition for skin containing germinated seeds of ginseng extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |